Article
[Novel mode of action of ribavirin (Rebetol), a drug for the treatment of chronic hepatitis C: inducting the mutation of RNA viruses].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 1 Dec 2002
Ogawa Masami, Morisada Akiko
Abstract excerpt
Ribavirin (Rebetol) is an antiviral agent used in combination with interferon alpha-2b (IFN alpha-2b) for the treatment of chronic hepatitis C. Ribavirin has been reported to have a broad-spectrum antiviral activity mainly against RNA viruses. The effect of ribavirin was potentiated when administered in combination with IFN alpha-2b in an antiviral assay using bovine viral diarrhea virus as a surrogate for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
